finasteride has been researched along with Cardiac Remodeling, Ventricular in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bauersachs, J; Froese, N; Geffers, R; Gigina, A; Gruh, I; Grund, A; Halloin, C; Heineke, J; Hofmann, M; Kilian, K; Korf-Klingebiel, M; Martin, U; Melchert, A; Scharf, G; Signorini, MER; Wang, H; Wang, Y; Wollert, KC; Zwadlo, C; Zweigerdt, R | 1 |
1 other study(ies) available for finasteride and Cardiac Remodeling, Ventricular
| Article | Year |
|---|---|
Anti-androgenic therapy with finasteride improves cardiac function, attenuates remodeling and reverts pathologic gene-expression after myocardial infarction in mice.
Topics: Analysis of Variance; Androgen Antagonists; Animals; Cardiomegaly; Cell Line; Dihydrotestosterone; Endothelial Cells; Fibroblasts; Fibrosis; Finasteride; Gene Expression; Human Umbilical Vein Endothelial Cells; Humans; Induced Pluripotent Stem Cells; Male; Mice; Muscle Contraction; Myocardial Infarction; Myocardium; Neovascularization, Physiologic; Rats; Rats, Sprague-Dawley; Ventricular Function, Left; Ventricular Remodeling | 2018 |